These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1820289)

  • 21. Missing data? Plan on it!
    Palmer RF; Royall DR
    J Am Geriatr Soc; 2010 Oct; 58 Suppl 2():S343-8. PubMed ID: 21029065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bootstrap analysis of multivariate failure time data.
    Monaco J; Cai J; Grizzle J
    Stat Med; 2005 Nov; 24(22):3387-400. PubMed ID: 16237657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reading a research article part II: parametric and nonparametric statistics.
    Oliver D; Mahon SM
    Clin J Oncol Nurs; 2005 Apr; 9(2):238-40. PubMed ID: 15853166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
    Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
    J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive data mining in clinical medicine: current issues and guidelines.
    Bellazzi R; Zupan B
    Int J Med Inform; 2008 Feb; 77(2):81-97. PubMed ID: 17188928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-dependent covariates in the proportional subdistribution hazards model for competing risks.
    Beyersmann J; Schumacher M
    Biostatistics; 2008 Oct; 9(4):765-76. PubMed ID: 18434297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Issues in applied statistics for public health bioterrorism surveillance using multiple data streams: research needs.
    Rolka H; Burkom H; Cooper GF; Kulldorff M; Madigan D; Wong WK
    Stat Med; 2007 Apr; 26(8):1834-56. PubMed ID: 17221940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statistical analysis of data from studies on experimental autoimmune encephalomyelitis.
    Fleming KK; Bovaird JA; Mosier MC; Emerson MR; LeVine SM; Marquis JG
    J Neuroimmunol; 2005 Dec; 170(1-2):71-84. PubMed ID: 16198426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimension reduction methods for microarrays with application to censored survival data.
    Li L; Li H
    Bioinformatics; 2004 Dec; 20(18):3406-12. PubMed ID: 15256406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generating survival times to simulate Cox proportional hazards models.
    Bender R; Augustin T; Blettner M
    Stat Med; 2005 Jun; 24(11):1713-23. PubMed ID: 15724232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markov models of aging: theory and practice.
    Steinsaltz D; Mohan G; Kolb M
    Exp Gerontol; 2012 Oct; 47(10):792-802. PubMed ID: 22750487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical methodology of meta-analysis of individual patient data using a survival outcome.
    Katsahian S; Latouche A; Mary JY; Chevret S; Porcher R
    Contemp Clin Trials; 2008 Mar; 29(2):220-30. PubMed ID: 17884735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey of statistical methodology used in Ethiopian health science research journals.
    Taddese Z
    Ethiop Med J; 2001 Jul; 39(3):229-39. PubMed ID: 11921553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social indicators.
    Sheldon EB; Parke R
    Science; 1975 May; 188(4189):693-8. PubMed ID: 17755166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-parametric assessment of non-inferiority with censored data.
    Freitag G; Lange S; Munk A
    Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing phase II studies in cancer with time-to-event endpoints.
    Owzar K; Jung SH
    Clin Trials; 2008; 5(3):209-21. PubMed ID: 18559409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistics review 12: survival analysis.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Oct; 8(5):389-94. PubMed ID: 15469602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint analysis of time-to-event and multiple binary indicators of latent classes.
    Larsen K
    Biometrics; 2004 Mar; 60(1):85-92. PubMed ID: 15032777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.